Description
Evorel Patches & Utrogestan – Combined Hormone Replacement Therapy
Evorel Transdermal Patches and Utrogestan 100mg Capsules are prescribed together to help manage symptoms associated with perimenopause and menopause.
During menopause, the ovaries gradually produce less oestrogen. This hormonal change can cause symptoms such as hot flushes, night sweats, sleep disruption and other difficulties that may affect everyday comfort and wellbeing.
This treatment combines two hormones with different roles:
Evorel – Estradiol (Oestrogen)
Evorel patches contain estradiol, a form of oestrogen that replaces declining natural hormone levels. The hormone is absorbed gradually through the skin, providing continuous oestrogen replacement.
Evorel is available in four strengths: 25mcg, 50mcg, 75mcg and 100mcg per 24 hours. The appropriate strength is selected according to symptom severity, treatment response and individual medical history.
Utrogestan – Micronised Progesterone
Utrogestan contains micronised progesterone, a hormone used alongside systemic oestrogen therapy in women who still have a womb.
Oestrogen can stimulate growth of the womb lining, known as the endometrium. Without adequate progesterone protection, this can increase the risk of endometrial hyperplasia and endometrial cancer.
Utrogestan helps counteract this effect and may be prescribed on a sequential or continuous schedule, depending on the patient’s menopausal stage and clinical requirements.
Together, these medicines offer an individualised HRT option combining transdermal oestrogen with oral micronised progesterone.
Evorel Strength Comparison
| Patch strength |
Estradiol delivered per 24 hours |
Dose category |
| Evorel 25 |
25mcg |
Lower dose |
| Evorel 50 |
50mcg |
Standard dose |
| Evorel 75 |
75mcg |
Higher dose |
| Evorel 100 |
100mcg |
Higher dose |
All four strengths are applied twice weekly. The strength refers to the amount of estradiol released every 24 hours, not the total amount of hormone contained within each patch.
Important: Higher-strength oestrogen patches may require a different progesterone regimen to provide adequate womb-lining protection. The prescriber must determine the appropriate Utrogestan dose and schedule.
Key Benefits
-
Helps relieve hot flushes and night sweats.
-
Replaces declining oestrogen levels during menopause.
-
Available in four Evorel strengths for individualised treatment.
-
Delivers oestrogen gradually through the skin.
-
Convenient twice-weekly patch application.
-
Provides an alternative to daily oral oestrogen tablets.
-
Includes micronised progesterone to help protect the womb lining.
-
May improve sleep disrupted by menopause symptoms.
-
Can be prescribed using sequential or continuous progesterone schedules.
-
Allows treatment adjustments according to clinical response.
Product Details
| Detail |
Information |
| Product Name |
Evorel Patches & Utrogestan 100mg |
| Evorel Strength Options |
25mcg, 50mcg, 75mcg, 100mcg per 24 hours |
| Evorel Active Ingredient |
Estradiol |
| Utrogestan Active Ingredient |
Micronised progesterone |
| Utrogestan Strength |
100mg per capsule |
| Evorel Pack Size |
24 patches |
| Utrogestan Pack Size |
90 capsules |
| Treatment Type |
Combined oestrogen and progesterone HRT |
| Administration |
Transdermal patches and oral capsules |
| Patch Frequency |
Twice weekly |
| Progesterone Frequency |
As prescribed |
| Evorel Pack Duration |
Approximately 12 weeks |
Directions
Evorel patches and Utrogestan capsules must be used according to the schedule prescribed by your doctor.
How to Apply Evorel Patches
-
Apply one patch twice weekly, changing it every three to four days.
-
Choose a clean, dry, hairless area of skin below the waist, preferably the thigh or bottom.
-
Open the protective sachet immediately before application.
-
Remove part of the protective backing without touching the adhesive surface.
-
Apply the patch firmly to the skin.
-
Remove the remaining backing and press the patch in place for at least 10 seconds.
-
Leave the patch in place until the next scheduled change.
-
Remove the old patch before applying a new one.
-
Rotate application sites, avoiding reuse of the same area for at least one week.
Never apply Evorel on or near the breasts, to irritated skin or to areas covered by tight waistbands. Do not cut the patch. Patches can normally remain in place during bathing, showering and swimming.
Example Patch Schedule
| Day |
Instructions |
| Monday |
Apply a new Evorel patch |
| Thursday |
Remove and replace the patch |
| Following Monday |
Replace the patch again |
| Continue |
Follow the same two days each week |
How to Take Utrogestan 100mg
-
Swallow the prescribed capsules whole with water.
-
Take at bedtime, at least two hours after food.
-
Follow the exact number of capsules and treatment days prescribed.
-
Do not increase or reduce the dose without medical advice.
Common Utrogestan Regimens
| Treatment regimen |
Example dosing schedule |
| Sequential |
200mg at bedtime on days 15–26 of a 28-day cycle |
| Alternative cyclical |
100mg at bedtime on days 1–25 of a 28-day cycle |
| Continuous |
100mg daily may be prescribed following individual assessment |
These schedules are examples rather than instructions for every patient. The correct progesterone regimen depends on the oestrogen dose, menopausal stage and individual clinical circumstances.
Side Effects
Like all medicines, Evorel and Utrogestan can cause side effects, although not everyone experiences them.
Evorel Patch Side Effects
-
Redness, itching or irritation at the application site.
-
-
Breast tenderness or discomfort.
-
Nausea or abdominal pain.
-
Vaginal spotting or irregular bleeding.
-
-
Fluid retention or swelling.
-
-
-
Utrogestan Side Effects
-
-
-
-
Nausea or abdominal discomfort.
-
Vaginal bleeding or changes in bleeding patterns.
-
-
-
Skin reactions or itching.
Some side effects may improve as the body adjusts to treatment. Contact your prescriber if symptoms are persistent, troublesome or worsening.
Serious Side Effects
Systemic HRT is associated with certain risks, including breast cancer, blood clots and stroke. Individual risks depend on age, medical history, treatment type, dose and duration.
Transdermal oestrogen is generally associated with a lower risk of blood clots than oral oestrogen, but clinical assessment remains important.
Seek emergency medical attention if you experience:
-
Sudden chest pain or difficulty breathing.
-
Painful swelling or redness in one leg.
-
Sudden facial weakness, difficulty speaking or other stroke symptoms.
-
Swelling of the face, tongue or throat with breathing difficulties.
Stop treatment and seek urgent medical advice if you develop jaundice, a new migraine-type headache, a significant increase in blood pressure or signs of a severe allergic reaction.
Ingredients
Evorel Patches – Active Ingredient
All four strengths contain estradiol, supplied as estradiol hemihydrate.
| Evorel strength |
Estradiol hemihydrate per patch |
Estradiol delivered per 24 hours |
| Evorel 25 |
1.6mg |
25mcg |
| Evorel 50 |
3.2mg |
50mcg |
| Evorel 75 |
4.8mg |
75mcg |
| Evorel 100 |
6.4mg |
100mcg |
Evorel Other Ingredients and Patch Materials
-
Acrylic adhesive polymer.
-
-
-
Protective release liner, removed before application.
Utrogestan 100mg Capsules – Active Ingredient
Each soft capsule contains 100mg micronised progesterone.
Utrogestan Other Ingredients
Allergy warning: Utrogestan contains soya lecithin and must not be used by people with peanut or soya allergies.
Warnings
Do Not Use This Combination If You:
-
Have, have previously had or are suspected of having breast cancer.
-
Have a known or suspected oestrogen-dependent cancer.
-
Have unexplained vaginal bleeding.
-
Have untreated endometrial hyperplasia.
-
Have or have previously had blood clots.
-
Have certain inherited blood-clotting disorders.
-
Have active or recent arterial thromboembolic disease.
-
Have liver disease where liver function has not returned to normal.
-
-
Are allergic to estradiol, progesterone or another ingredient.
-
Have a peanut or soya allergy, because Utrogestan contains soya lecithin.
Consult Your Doctor Before Treatment If You Have:
-
Uterine fibroids or endometriosis.
-
High blood pressure or diabetes.
-
Migraines or severe headaches.
-
Gallstones or liver problems.
-
-
Heart or kidney conditions.
-
A family history of breast cancer.
-
An increased risk of blood clots.
-
Systemic lupus erythematosus.
-
High triglyceride levels.
-
A history of endometrial hyperplasia.
Additional Safety Information
-
Women who still have a womb generally require adequate progesterone protection alongside systemic oestrogen.
-
Higher oestrogen doses may require an adjusted progesterone regimen.
-
This treatment is not a contraceptive.
-
Do not use during pregnancy or breastfeeding.
-
Utrogestan may cause drowsiness or dizziness; avoid driving if affected.
-
Inform your doctor about all medicines and herbal supplements you take, including St John’s wort.
-
Certain medicines for epilepsy, tuberculosis and HIV may interact with HRT.
-
Tell your doctor before planned surgery or prolonged immobilisation.
-
Attend regular HRT reviews and recommended breast screening.
-
Report unexpected or persistent vaginal bleeding.
-
Evorel 25 is not licensed for osteoporosis prevention. Evorel 50, 75 and 100 have an additional licensed indication for selected postmenopausal women when other approved treatments are unsuitable.
Storage
Evorel Patches
-
-
Keep patches in their original sealed protective sachets.
-
Keep out of the sight and reach of children and pets.
-
Open each sachet only when ready to apply the patch.
-
Do not use after the expiry date.
-
Fold used patches in half with the adhesive sides together.
-
Return unwanted or expired patches to a pharmacy for safe disposal.
Utrogestan 100mg Capsules
-
Keep capsules in their original packaging.
-
Follow the storage instructions printed on the supplied pack.
-
Keep out of the sight and reach of children.
-
Do not use after the expiry date.
-
Return unused or expired capsules to a pharmacy for safe disposal.
Reviews
There are no reviews yet.